Importance of World Glaucoma Day

Article

Your thoughts on the efficacy of initiatives such as World Glaucoma Day.

Key Points

World Glaucoma Day on March 12th saw huge participation amongst the ophthalmology community across both Europe and the rest of the world and the message from its organisers was clear - the role of the clinician in the early detection of glaucoma cannot be overemphasized. But what did you think?

"Glaucoma is a slowly progressive degeneration of the optic nerves. It is often (but not always) associated with elevated IOP. The vision loss in glaucoma occurs first in the periphery before involving the central vision. Patients are, therefore, unaware of the progressive loss of peripheral vision until the very advanced stages of the disease," said Dr. Ritchie, co-chairman of the World Glaucoma Day Committee of the World Glaucoma Association.

Effective screening for glaucoma includes some additional tests. "Of course, no examination is complete without darkroom gonioscopy to identify angle closure, IOP measurement, and examination of the optic nerves for disc haemorrhage, parapapillary atrophy, nerve fibre layer defects, and the appearance of the neuroretinal rim. Patients with risk factors for glaucoma or a suggestive clinical examination may then undergo the appropriate perimetric testing and imaging of the optic nerve head to assess the extent of disease. Stereoscopic disc photography in patients with glaucoma risk factors is a powerful tool to establish a baseline and detect future pre-perimetric glaucomatous change," noted Dr. Angelilli, a clinical instructor at the New York University Medical Centre.

If you are not already a member of the European ophthalmology community go to http://www.oteurope.com/forum/ or pose your questions to colleagues at http://www.oteurope.com/discuss/

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.